For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Continuous Glucose Monitoring - Congenital hyperinsulinism
PAD Profile : Continuous Glucose Monitoring - Congenital hyperinsulinism
Traffic Light Status
Status 1 of 1.
- Device
Patients must be under the care of a national CHI centre (see PAD for details).
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
Additional Documents
No additional documents returned.
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves real time continuous glucose monitoring (RTCGM) devices for patients with congenital hyperinsulinism (CHI) who are under the care of one of the 3 nationally commissioned centres:
· Great Ormond Street Hospital for Children NHS Foundation Trust
· Manchester University NHS Foundation Trust
· Alder Hey Children’s NHS Foundation Trust
AND who require overnight continuous enteral glucose delivery via a gastrostomy feed pump. rtCGM acts as an additional alert in case of gastrostomy feed pump failure.
RTCGM will be given a RED traffic light status for this indication.